Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Trazodone and Chlorpromazine might help treat sexual dysfunction from finasteride and SSRIs.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A medication called sodium valproate likely caused a girl's hair to become kinky and dry.

A new combination of tadalafil and finasteride improves drug performance and stability.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

These medications for BPH have known risks and may have new side effects.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Errors found in identifying furosemide and finasteride polymorphs due to incomplete data.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.